These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 6184140)

  • 1. [Progress in the study of an interferon inducer, poly I:C, and evaluation of its clinical effects].
    Zhang LX
    Zhonghua Yi Xue Za Zhi; 1982 Aug; 62(8):502-3. PubMed ID: 6184140
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon induction in cancer: with some observations on the clinical effects of poly 1:C.
    Young CW
    Med Clin North Am; 1971 May; 55(3):721-8. PubMed ID: 4932880
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of 5-fluorouracil-induced toxicity in mice with interferon or with the interferon inducer, polyinosinic-polycytidylic acid.
    Stolfi RL; Martin DS; Sawyer RC; Spiegelman S
    Cancer Res; 1983 Feb; 43(2):561-6. PubMed ID: 6184150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of oxyphenbutazone on Poly I:C induced interferon formation in animal experiments].
    Kunz C; Hofmann H
    Arzneimittelforschung; 1971 Jul; 21(7):1032-3. PubMed ID: 5109491
    [No Abstract]   [Full Text] [Related]  

  • 5. TLR3: interferon induction by double-stranded RNA including poly(I:C).
    Matsumoto M; Seya T
    Adv Drug Deliv Rev; 2008 Apr; 60(7):805-12. PubMed ID: 18262679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of interferon in the anti-melanoma effects of poly (I).poly (C) and Newcastle disease virus.
    Bart RS; Kopf AW; Vilcek JT; Lam S
    Nat New Biol; 1973 Oct; 245(147):229-30. PubMed ID: 4518363
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of interferon in eye infections of man.
    Guerra R; Galin MA; Frezzotti R
    Tex Rep Biol Med; 1977; 35():497-500. PubMed ID: 358471
    [No Abstract]   [Full Text] [Related]  

  • 8. [Corneal herpes--treatment with interferon inductors].
    Doden W; Lieb W; Wacker A
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1970; 70():434-8. PubMed ID: 5537504
    [No Abstract]   [Full Text] [Related]  

  • 9. Participation of cellular membraneous system in the production of chick cell interferon.
    Kono S; Koase M; Sakata H; Shimizu Y
    Jpn J Med Sci Biol; 1971 Apr; 24(2):134. PubMed ID: 5314748
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of interferon on thoracic duct lymphocyte output: induction with either poly I:poly C or vaccinia virus.
    Korngold R; Blank KJ; Murasko DM
    J Immunol; 1983 May; 130(5):2236-40. PubMed ID: 6187846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon and natural killer (NK) cells.
    Herberman RB; Ortaldo JR; Timonen T; Reynolds CW; Djeu JY; Pestka S; Stanton J
    Tex Rep Biol Med; 1981-1982; 41():590-5. PubMed ID: 6189224
    [No Abstract]   [Full Text] [Related]  

  • 12. Poly I-Mercapto Poly C: antiviral, anticellular, and pharmacologic effects.
    Vastola KA; Ho YK; Bardos TJ; Grossmayer BJ; Fruck-Diviak L; O'Malley JA
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):407-19. PubMed ID: 6438740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Herpes simplex keratitis treated with interferon inducer poly I:C (author's transl)].
    Gong XM
    Zhonghua Yan Ke Za Zhi; 1981 Nov; 17(6):340-3. PubMed ID: 6806028
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental ocular studies with polyinosinic acid: polycytidylic acid.
    McDonald TO
    Eye Ear Nose Throat Mon; 1973 Feb; 52(2):45-52. PubMed ID: 4346077
    [No Abstract]   [Full Text] [Related]  

  • 15. New approaches to the treatment of AIDS with special reference to overcoming interferon resistance.
    Ambrus JL; Ambrus JL; Bardos TJ; Dembinski W; Chadha KC
    J Med; 2004; 35(1-6):201-9. PubMed ID: 18084878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
    Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
    Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal modulation of interferon response in spotted sousliks (Spermophilus suslicus).
    Kandefer-Szerszeń M; Meczyński S; Borowska L; Szuster-Ciesielska A; Rzeski W
    Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):425-31. PubMed ID: 8572902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the recreational agent isobutyl nitrite on human peripheral blood leukocytes and on in vitro interferon production.
    Hersh EM; Reuben JM; Bogerd H; Rosenblum M; Bielski M; Mansell PW; Rios A; Newell GR; Sonnenfeld G
    Cancer Res; 1983 Mar; 43(3):1365-71. PubMed ID: 6186374
    [No Abstract]   [Full Text] [Related]  

  • 19. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
    Jasani B; Navabi H; Adams M
    Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model.
    Sakurai F; Terada T; Maruyama M; Watanabe Y; Yamashita F; Takakura Y; Hashida M
    Cancer Gene Ther; 2003 Sep; 10(9):661-8. PubMed ID: 12944985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.